{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,4]],"date-time":"2026-03-04T09:13:05Z","timestamp":1772615585965,"version":"3.50.1"},"reference-count":53,"publisher":"MDPI AG","issue":"3","license":[{"start":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T00:00:00Z","timestamp":1772064000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100017638","name":"Ministry of Health of the Russian Federation","doi-asserted-by":"publisher","award":["125040704919-6"],"award-info":[{"award-number":["125040704919-6"]}],"id":[{"id":"10.13039\/501100017638","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Antibiotics"],"abstract":"<jats:p>Background\/Objectives: Influenza B virus infection contributes substantially to annual morbidity and mortality, accounting for 20% to 30% of influenza-associated deaths worldwide. Although vaccination reduces the risk of severe disease, widely used inactivated influenza vaccines are often insufficient to prevent virus transmission. Moreover, influenza B viruses are less susceptible to commonly used antivirals than influenza A viruses. New approaches are therefore required to decrease disease burden and limit virus spread. Neomycin, an aminoglycoside antibiotic, was recently shown to mitigate SARS-CoV-2 transmission in a hamster model. Here, we conducted an exploratory study to assess the effect of neomycin on influenza B virus transmission. Methods: Contact transmission was evaluated using a guinea pig model (n = 4 per group), and aerosol transmission was assessed using a ferret model (n = 6 per group). Animals in the experimental groups received neomycin sulfate (5 mg\/guinea pig, 20 mg\/ferret) or placebo intranasally, starting one day before exposure to infected animals and continuing for four days thereafter. In the guinea pig study, an additional control group received intranasal interferon alpha. Viral transmission to contact animals was assessed by RT-PCR and virus culture of nasal washes collected over two weeks. Clinical signs and body weight were monitored daily. Results: In the guinea pig model, 75% of contact animals became infected with influenza B virus regardless of treatment. Neither neomycin nor interferon alpha prevented infection, although both delayed the onset of viral shedding in contact animals. In the ferret model, infection occurred in 33% of placebo-treated contact animals, whereas no viral shedding was detected in the neomycin-treated group. Conclusions: Prophylactic intranasal neomycin treatment has the potential to protect exposed individuals from aerosol transmission of influenza B virus during influenza outbreaks.<\/jats:p>","DOI":"10.3390\/antibiotics15030245","type":"journal-article","created":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T16:57:13Z","timestamp":1772125033000},"page":"245","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Pre-Exposure Intranasal Treatment with Neomycin Sulfate Reduces Transmission of Influenza B Virus"],"prefix":"10.3390","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0411-9896","authenticated-orcid":false,"given":"Mariia V.","family":"Sergeeva","sequence":"first","affiliation":[{"name":"Smorodintsev Research Institute of Influenza, The Ministry of Health of the Russian Federation, 197022 St Petersburg, Russia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daria","family":"Shamakova","sequence":"additional","affiliation":[{"name":"Smorodintsev Research Institute of Influenza, The Ministry of Health of the Russian Federation, 197022 St Petersburg, Russia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kira","family":"Kudrya","sequence":"additional","affiliation":[{"name":"Smorodintsev Research Institute of Influenza, The Ministry of Health of the Russian Federation, 197022 St Petersburg, Russia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nikita","family":"Zagriadskii","sequence":"additional","affiliation":[{"name":"Smorodintsev Research Institute of Influenza, The Ministry of Health of the Russian Federation, 197022 St Petersburg, Russia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-3748-530X","authenticated-orcid":false,"given":"Daria M.","family":"Karachevtseva","sequence":"additional","affiliation":[{"name":"Home of Pharmacy, Research and Manufacturing Company (RMC), 188663 Kuzmolovskiy, Russia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7478-4942","authenticated-orcid":false,"given":"Aleksandr A.","family":"Matichin","sequence":"additional","affiliation":[{"name":"Home of Pharmacy, Research and Manufacturing Company (RMC), 188663 Kuzmolovskiy, Russia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arman","family":"Muzhikyan","sequence":"additional","affiliation":[{"name":"Smorodintsev Research Institute of Influenza, The Ministry of Health of the Russian Federation, 197022 St Petersburg, Russia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marina","family":"Stukova","sequence":"additional","affiliation":[{"name":"Smorodintsev Research Institute of Influenza, The Ministry of Health of the Russian Federation, 197022 St Petersburg, Russia"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2026,2,26]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","unstructured":"Ashraf, M.A., Raza, M.A., Amjad, M.N., Ud Din, G., Yue, L., Shen, B., Chen, L., Dong, W., Xu, H., and Hu, Y. (2024). A comprehensive review of influenza B virus, its biological and clinical aspects. Front. Microbiol., 15.","DOI":"10.3389\/fmicb.2024.1467029"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"104970","DOI":"10.1016\/j.antiviral.2020.104970","article-title":"Burden of influenza B virus infection and considerations for clinical management","volume":"185","author":"Zaraket","year":"2021","journal-title":"Antivir. Res."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"2803","DOI":"10.1128\/JVI.02424-08","article-title":"Blocking interhost transmission of influenza virus by vaccination in the guinea pig model","volume":"83","author":"Lowen","year":"2009","journal-title":"J. Virol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1093\/cid\/cit060","article-title":"Influenza vaccine effectiveness in the community and the household","volume":"56","author":"Ohmit","year":"2013","journal-title":"Clin. Infect. Dis."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1086\/509925","article-title":"Lower clinical effectiveness of oseltamivir against influenza B contrasted with influenza A infection in children","volume":"44","author":"Sugaya","year":"2007","journal-title":"Clin. Infect. Dis."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1969","DOI":"10.3201\/eid2510.190607","article-title":"Susceptibility of Influenza A, B, C, and D Viruses to Baloxavir1","volume":"25","author":"Mishin","year":"2019","journal-title":"Emerg. Infect. Dis."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1038\/s41564-018-0138-2","article-title":"Topical application of aminoglycoside antibiotics enhances host resistance to viral infections in a microbiota-independent manner","volume":"3","author":"Gopinath","year":"2018","journal-title":"Nat. Microbiol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"3388","DOI":"10.1128\/jvi.61.11.3388-3393.1987","article-title":"Evidence that neomycin inhibits binding of herpes simplex virus type 1 to the cellular receptor","volume":"61","author":"Langeland","year":"1987","journal-title":"J. Virol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"15612","DOI":"10.1021\/bi0108655","article-title":"Neomycin B\u2212arginine conjugate, a novel HIV-1 Tat antagonist: Synthesis and anti-HIV activities","volume":"40","author":"Litovchick","year":"2001","journal-title":"Biochemistry"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.aaf.2018.09.003","article-title":"In vivo effects of neomycin sulfate on non-specific immunity, oxidative damage and replication of cyprinid herpesvirus 2 in crucian carp (Carassius auratus gibelio)","volume":"4","author":"Sun","year":"2019","journal-title":"Aquac. Fish."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"e0078322","DOI":"10.1128\/mbio.00783-22","article-title":"Aminoglycoside Antibiotics Inhibit Phage Infection by Blocking an Early Step of the Infection Cycle","volume":"13","author":"Kever","year":"2022","journal-title":"mBio"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"97","DOI":"10.2147\/JEP.S346006","article-title":"Antiviral Activity of Approved Antibacterial, Antifungal, Antiprotozoal and Anthelmintic Drugs: Chances for Drug Repurposing for Antiviral Drug Discovery","volume":"14","author":"Abdulaziz","year":"2022","journal-title":"J. Exp. Pharmacol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"e2319566121","DOI":"10.1073\/pnas.2319566121","article-title":"Intranasal neomycin evokes broad-spectrum antiviral immunity in the upper respiratory tract","volume":"121","author":"Mao","year":"2024","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"9988","DOI":"10.1073\/pnas.0604157103","article-title":"The guinea pig as a transmission model for human influenza viruses","volume":"103","author":"Lowen","year":"2006","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_15","first-page":"157","article-title":"Transmission in the guinea pig model","volume":"385","author":"Lowen","year":"2014","journal-title":"Curr. Top. Microbiol. Immunol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"e0105723","DOI":"10.1128\/jvi.01057-23","article-title":"Immunity induced by vaccination with recombinant influenza B virus neuraminidase protein breaks viral transmission chains in guinea pigs in an exposure intensity-dependent manner","volume":"97","author":"McMahon","year":"2023","journal-title":"J. Virol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"2851","DOI":"10.1128\/JVI.02174-08","article-title":"Pathogenesis of 1918 pandemic and H5N1 influenza virus infections in a guinea pig model: Antiviral potential of exogenous alpha interferon to reduce virus shedding","volume":"83","author":"Belser","year":"2009","journal-title":"J. Virol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"965","DOI":"10.3201\/eid2406.172114","article-title":"Ferrets as Models for Influenza Virus Transmission Studies and Pandemic Risk Assessments","volume":"24","author":"Belser","year":"2018","journal-title":"Emerg. Infect. Dis."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"13524","DOI":"10.1038\/s41598-024-63314-2","article-title":"Induction and antiviral activity of ferret myxovirus resistance (Mx) protein 1 against influenza A viruses","volume":"14","author":"Farrukee","year":"2024","journal-title":"Sci. Rep."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"e07969","DOI":"10.7554\/eLife.07969","article-title":"Mapping influenza transmission in the ferret model to transmission in humans","volume":"4","author":"Buhnerkempe","year":"2015","journal-title":"eLife"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1128\/JVI.01732-09","article-title":"Transmission of pandemic H1N1 influenza virus and impact of prior exposure to seasonal strains or interferon treatment","volume":"84","author":"Steel","year":"2010","journal-title":"J. Virol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.coviro.2015.06.002","article-title":"Animal models for influenza virus transmission studies: A historical perspective","volume":"13","author":"Bouvier","year":"2015","journal-title":"Curr. Opin. Virol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"e0113721","DOI":"10.1128\/AAC.01137-21","article-title":"Baloxavir Treatment Delays Influenza B Virus Transmission in Ferrets and Results in Limited Generation of Drug-Resistant Variants","volume":"65","author":"Pascua","year":"2021","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"4279","DOI":"10.1128\/JVI.06645-11","article-title":"Transmission of influenza B viruses in the guinea pig","volume":"86","author":"Pica","year":"2012","journal-title":"J. Virol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"e0092721","DOI":"10.1128\/msphere.00927-21","article-title":"Murine Broadly Reactive Antineuraminidase Monoclonal Antibodies Protect Mice from Recent Influenza B Virus Isolates and Partially Inhibit Virus Transmission in the Guinea Pig Model","volume":"7","author":"Tan","year":"2022","journal-title":"mSphere"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1089\/vim.2009.0045","article-title":"Influenza B virus causes milder pathogenesis and weaker inflammatory responses in ferrets than influenza A virus","volume":"22","author":"Kim","year":"2009","journal-title":"Viral Immunol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"e0149423","DOI":"10.1128\/jvi.01494-23","article-title":"Differential interferon responses to influenza A and B viruses in primary ferret respiratory epithelial cells","volume":"98","author":"Rowe","year":"2024","journal-title":"J. Virol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"e0236124","DOI":"10.1128\/mbio.02361-24","article-title":"Delay of innate immune responses following influenza B virus infection affects the development of a robust antibody response in ferrets","volume":"16","author":"Rowe","year":"2025","journal-title":"mBio"},{"key":"ref_29","doi-asserted-by":"crossref","unstructured":"Dissanayake, T.K., Sch\u00e4uble, S., Mirhakkak, M.H., Wu, W.L., Ng, A.C., Yip, C.C.Y., L\u00f3pez, A.G., Wolf, T., Yeung, M.L., and Chan, K.H. (2020). Comparative Transcriptomic Analysis of Rhinovirus and Influenza Virus Infection. Front. Microbiol., 11.","DOI":"10.3389\/fmicb.2020.602854"},{"key":"ref_30","first-page":"684","article-title":"Risk factors of influenza transmission in households","volume":"54","author":"Viboud","year":"2004","journal-title":"Br. J. Gen. Pract."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"1935","DOI":"10.1038\/ncomms2922","article-title":"Aerosol transmission is an important mode of influenza A virus spread","volume":"4","author":"Cowling","year":"2013","journal-title":"Nat. Commun."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"e0055922","DOI":"10.1128\/jvi.00559-22","article-title":"Induction of Interferon-Stimulated Genes Correlates with Reduced Growth of Influenza A Virus in Lungs after RIG-I Agonist Treatment of Ferrets","volume":"96","author":"Schwab","year":"2022","journal-title":"J. Virol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"961","DOI":"10.2217\/fmb.13.64","article-title":"Considerations regarding appropriate sample size for conducting ferret transmission experiments","volume":"8","author":"Belser","year":"2013","journal-title":"Future Microbiol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1001\/jama.2023.0064","article-title":"Household Transmission of Influenza A Viruses in 2021\u20132022","volume":"329","author":"Rolfes","year":"2023","journal-title":"JAMA"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"e2446814","DOI":"10.1001\/jamanetworkopen.2024.46814","article-title":"Estimated Effectiveness of Influenza Vaccines in Preventing Secondary Infections in Households","volume":"7","author":"Grijalva","year":"2024","journal-title":"JAMA Netw. Open"},{"key":"ref_36","doi-asserted-by":"crossref","unstructured":"Cowling, B.J., Ip, D.K., Fang, V.J., Suntarattiwong, P., Olsen, S.J., Levy, J., Uyeki, T.M., Leung, G.M., Peiris, J.S., and Chotpitayasunondh, T. (2014). Modes of transmission of influenza B virus in households. PLoS ONE, 9.","DOI":"10.1371\/journal.pone.0108850"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1186\/s12985-015-0272-x","article-title":"Clinical response to pandemic H1N1 influenza virus from a fatal and mild case in ferrets","volume":"12","author":"Martorell","year":"2015","journal-title":"Virol. J."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1111\/1348-0421.13179","article-title":"Efficacy of an Inactivated Whole-Virus A\/Victoria\/361\/2011 (IVR-165) (H3N2) Influenza Vaccine in Ferrets","volume":"68","author":"Kishida","year":"2024","journal-title":"Microbiol. Immunol."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"13480","DOI":"10.1128\/JVI.02434-13","article-title":"Impact of prior seasonal H3N2 influenza vaccination or infection on protection and transmission of emerging variants of influenza A(H3N2)v virus in ferrets","volume":"87","author":"Houser","year":"2013","journal-title":"J. Virol."},{"key":"ref_40","unstructured":"Veirup, N., and Kyriakopoulos, C. (2025). Neomycin. StatPearls [Internet], StatPearls Publishing."},{"key":"ref_41","unstructured":"(2025, December 28). Recommendation of the Eurasian Economic Commission Board No. 33, Dated 14 November 2023. On the Guidelines for Working with Laboratory (Experimental) Animals During Preclinical (Non-Clinical) Research. Electronic Recourse. (In Russian)."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/S0169-409X(97)00059-8","article-title":"Nasal mucociliary clearance as a factor in nasal drug delivery","volume":"29","author":"Merkus","year":"1998","journal-title":"Adv. Drug Deliv. Rev."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1093\/infdis\/126.4.387","article-title":"Immunity to influenza in ferrets. 3. Proteins in nasal secretions","volume":"126","author":"Potter","year":"1972","journal-title":"J. Infect. Dis."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"5354","DOI":"10.1073\/pnas.1019378108","article-title":"Microbiota regulates immune defense against respiratory tract influenza A virus infection","volume":"108","author":"Ichinohe","year":"2011","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1093\/oxfordjournals.aje.a118408","article-title":"A simple method of estimating fifty percent endpoints","volume":"27","author":"Reed","year":"1938","journal-title":"Am. J. Epidemiol."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"1821","DOI":"10.3201\/eid2707.210462","article-title":"Multiplex Real-Time Reverse Transcription PCR for Influenza A Virus, Influenza B Virus, and Severe Acute Respiratory Syndrome Coronavirus 2","volume":"27","author":"Shu","year":"2021","journal-title":"Emerg. Infect. Dis."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1038\/s44298-024-00074-w","article-title":"Optimal thresholds and key parameters for predicting influenza A virus transmission events in ferrets","volume":"2","author":"Kieran","year":"2024","journal-title":"npj Viruses"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/s41073-019-0069-3","article-title":"A randomised controlled trial of an Intervention to Improve Compliance with the ARRIVE guidelines (IICARus)","volume":"4","author":"Hair","year":"2019","journal-title":"Res. Integr. Peer Rev."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1016\/j.jss.2018.10.038","article-title":"Systematic Review on Characteristics and Reporting Quality of Animal Studies in Liver Regeneration Triggered by Portal Vein Occlusion and Associating Liver Partition and Portal Vein Ligation for Staged Hepatectomy: Adherence to the ARRIVE Guidelines","volume":"235","author":"Tihanyi","year":"2019","journal-title":"J. Surg. Res."},{"key":"ref_50","doi-asserted-by":"crossref","unstructured":"Zhao, B., Jiang, Y., Zhang, T., Shang, Z., Zhang, W., Hu, K., Chen, F., Mei, F., Gao, Q., and Zhao, L. (2020). Quality of interventional animal experiments in Chinese journals: Compliance with ARRIVE guidelines. BMC Vet. Res., 16.","DOI":"10.1186\/s12917-020-02664-1"},{"key":"ref_51","doi-asserted-by":"crossref","unstructured":"Han, S., Olonisakin, T.F., Pribis, J.P., Zupetic, J., Yoon, J.H., Holleran, K.M., Jeong, K., Shaikh, N., Rubio, D.M., and Lee, J.S. (2017). A checklist is associated with increased quality of reporting preclinical biomedical research: A systematic review. PLoS ONE, 12.","DOI":"10.1371\/journal.pone.0183591"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1681\/ASN.2018050515","article-title":"Quantity and Reporting Quality of Kidney Research","volume":"30","author":"Chatzimanouil","year":"2019","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_53","doi-asserted-by":"crossref","unstructured":"Leung, V., Rousseau-Blass, F., Beauchamp, G., and Pang, D.S. (2018). ARRIVE has not ARRIVEd: Support for the ARRIVE (Animal Research: Reporting of in vivo Experiments) guidelines does not improve the reporting quality of papers in animal welfare, analgesia or anesthesia. PLoS ONE, 13.","DOI":"10.1371\/journal.pone.0197882"}],"container-title":["Antibiotics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2079-6382\/15\/3\/245\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,4]],"date-time":"2026-03-04T05:25:35Z","timestamp":1772601935000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2079-6382\/15\/3\/245"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,26]]},"references-count":53,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2026,3]]}},"alternative-id":["antibiotics15030245"],"URL":"https:\/\/doi.org\/10.3390\/antibiotics15030245","relation":{},"ISSN":["2079-6382"],"issn-type":[{"value":"2079-6382","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,26]]}}}